Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Persistence with stroke prevention medications 3 months after hospitalization.

Bushnell CD, Zimmer LO, Pan W, Olson DM, Zhao X, Meteleva T, Schwamm L, Ovbiagele B, Williams L, Labresh KA, Peterson ED; Adherence Evaluation After Ischemic Stroke–Longitudinal Investigators.

Arch Neurol. 2010 Dec;67(12):1456-63. doi: 10.1001/archneurol.2010.190. Epub 2010 Aug 9.

PMID:
20697032
2.

In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.

Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B.

J Stroke Cerebrovasc Dis. 2008 Jan-Feb;17(1):5-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.09.004.

PMID:
18190814
3.

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics.

Bushnell C, Zimmer L, Schwamm L, Goldstein LB, Clapp-Channing N, Harding T, Drew L, Zhao X, Peterson E; AVAIL registry.

Am Heart J. 2009 Mar;157(3):428-435.e2. doi: 10.1016/j.ahj.2008.11.002.

PMID:
19249411
4.

Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry.

Ji R, Liu G, Shen H, Wang Y, Li H, Peterson E, Wang Y.

Neurol Res. 2013 Jan;35(1):29-36. doi: 10.1179/1743132812Y.0000000107.

PMID:
23317796
5.

Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack.

Scott DP, Greenfield JR, Bramah V, Alford J, Bennett C, Markus R, Campbell LV.

Intern Med J. 2010 Apr;40(4):275-80. doi: 10.1111/j.1445-5994.2009.01941.x. Epub 2009 Mar 9.

PMID:
19383060
6.

Secondary prevention of stroke.

MacDougall NJ, Amarasinghe S, Muir KW.

Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1103-15. doi: 10.1586/erc.09.77. Review.

PMID:
19764863
7.

Similar secondary stroke prevention and medication persistence rates among rural and urban patients.

Rodriguez D, Cox M, Zimmer LO, Olson DM, Goldstein LB, Drew L, Peterson ED, Bushnell CD; AVAIL Investigators.

J Rural Health. 2011 Winter;27(4):401-8. doi: 10.1111/j.1748-0361.2010.00352.x. Epub 2011 Jan 4.

PMID:
21967384
8.

[A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].

Ma RH, Wang YJ, Wang CX, Zhao XQ, Wang YL, Xu MJ, Wei M, Li Y, Zhang Z, Zhang WW, Wang L, Lin L, Li HT, Zheng T, Wang XW, Li JJ, Lü Y, Qi D.

Zhonghua Yi Xue Za Zhi. 2008 Oct 14;88(37):2618-22. Chinese.

PMID:
19080709
9.

Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack Patients.

Van Schaik SM, Van den Berg-Vos RM, Weinstein HC, Bosboom WM.

J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1378-82. doi: 10.1016/j.jstrokecerebrovasdis.2015.02.023. Epub 2015 Mar 21.

PMID:
25804570
10.

An evaluation of stroke education in AVAIL registry hospitals.

West A, Cox M, Zimmer LO, Fedder W, Weber C, Drew L, Peterson ED, Bushnell C, Olson DM.

J Neurosci Nurs. 2012 Jun;44(3):115-23. doi: 10.1097/JNN.0b013e3182510657.

PMID:
22555348
11.

Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.

Tentschert S, Parigger S, Dorda V, Bittner K, Unterbuchschachner D, Greisenegger S, Wimmer R, Brücke T, Lang W, Lalouschek W; Vienna Stroke Study Group.

Wien Klin Wochenschr. 2004 Dec 30;116(24):834-8.

PMID:
15690967
12.

Secondary prevention of ischaemic stroke and TIA.

Diener HC.

Cardiovasc J Afr. 2008 Jul-Aug;19(4):229. No abstract available.

13.

[Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].

Sander D, Schwertfeger M, Köfüncü E, Diehm C, Pittrow D.

Dtsch Med Wochenschr. 2008 Sep;133(36):1773-8. doi: 10.1055/s-0028-1082810. Epub 2008 Sep 2. German.

PMID:
18767003
14.

The utilization status of aspirin for the secondary prevention of ischemic stroke.

Ke XJ, Yu YF, Guo ZL, Xu K, Hai H, Zhang AH, Jiang H, Peng H.

Chin Med J (Engl). 2009 Jan 20;122(2):165-8.

PMID:
19187640
15.

Secondary preventive medication persistence and adherence 1 year after stroke.

Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, Alberts MJ, Fagan SC, Fonarow GC, Johnston SC, Kidwell C, Labresh KA, Ovbiagele B, Schwamm L, Peterson ED; AVAIL Investigators.

Neurology. 2011 Sep 20;77(12):1182-90. doi: 10.1212/WNL.0b013e31822f0423. Epub 2011 Sep 7.

16.

Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

Kirshner HS.

Int J Clin Pract. 2007 Oct;61(10):1739-48. Review. Erratum in: Int J Clin Pract. 2007 Nov;61(11):1957.

17.

Multicenter external validation of the ABCD2 score in triaging TIA patients.

Tsivgoulis G, Stamboulis E, Sharma VK, Heliopoulos I, Voumvourakis K, Teoh HL, Patousi A, Andrikopoulou A, Lim EL, Stilou L, Sim TB, Chan BP, Stefanis L, Vadikolias K, Piperidou C.

Neurology. 2010 Apr 27;74(17):1351-7. doi: 10.1212/WNL.0b013e3181dad63e.

PMID:
20421579
18.

Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack.

Yeh PS, Lin HJ, Bai CH, Hsieh FI, Ke DS, Li YH; Taiwan Stroke Registry.

Am J Cardiol. 2010 May 15;105(10):1490-4. doi: 10.1016/j.amjcard.2009.07.065. Epub 2010 Mar 30.

PMID:
20451701
19.

[Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].

Barinagarrementeria F, Arauz A, Ruiz-Sandoval JL, Cantú C, Leyva A, Murillo L, Villarreal J, Vargas RD, Alegría MA, Merino JG, Romano J; Asociación Mexicana de Enfermedad Vascular Cerebral.

Rev Invest Clin. 2010 Mar-Apr;62(2):135-40. Spanish. No abstract available.

PMID:
20597393
20.

Dipyridamole-associated headache in stroke patients--interindividual differences?

Lökk J.

Eur Neurol. 2009;62(2):109-13. doi: 10.1159/000222782. Epub 2009 Jun 12.

PMID:
19521087

Supplemental Content

Support Center